🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
15152
CAS Number:
61036-64-4
Teicoplanine
Synonym(s):
Teichomycine
Antibiotic
Documents
$70.00 /100 mg
Taille
Request Bulk Quote
Product Information

Teicoplanin is a glycopeptide antibiotic renowned for its potent antibacterial properties, particularly against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). This compound is primarily utilized in clinical settings for the treatment of serious infections, such as endocarditis and skin infections, where traditional antibiotics may fail. Its unique mechanism of action involves inhibiting cell wall synthesis, making it a critical option in antibiotic therapy.

In addition to its therapeutic applications, Teicoplanin is also employed in research settings to study bacterial resistance mechanisms and the development of new antimicrobial agents. Its stability and effectiveness in various formulations enhance its appeal in both pharmaceutical and biotechnological industries. Researchers and healthcare professionals appreciate Teicoplanin for its broad-spectrum efficacy and low toxicity profile, making it a valuable asset in the ongoing battle against antibiotic-resistant pathogens.

Synonyms
Teichomycine
CAS Number
61036-64-4
Molecular Formula
C 142 H 245 N 12 O 69 P
Molecular Weight
3255.51
MDL Number
MFCD05664625
PubChem ID
155885919
Appearance
Poudre blanche jaunâtre claire
Conditions
Conserver à 0 - 8 °C
Potency
≥ 900 ìg/mg (base anhydre)
General Information
Synonyms
Teichomycine
CAS Number
61036-64-4
Molecular Formula
C 142 H 245 N 12 O 69 P
Molecular Weight
3255.51
MDL Number
MFCD05664625
PubChem ID
155885919
Appearance
Poudre blanche jaunâtre claire
Conditions
Conserver à 0 - 8 °C
Potency
≥ 900 ìg/mg (base anhydre)
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Oui
DEA-regulated
Non
Warnings
-
Applications

Teicoplanin is widely utilized in research focused on

  • Antibiotic Therapy: It is primarily used to treat serious infections caused by Gram-positive bacteria, particularly in patients who are allergic to penicillin. This makes it a crucial option in hospitals for treating conditions like endocarditis and skin infections.
  • Pharmaceutical Development: Researchers employ teicoplanin in the development of new antibiotic formulations, leveraging its unique properties to combat antibiotic resistance, which is a growing concern in modern medicine.
  • Clinical Microbiology: It serves as a reference standard in microbiological testing and susceptibility assays, helping laboratories accurately determine the effectiveness of antibiotics against specific bacterial strains.
  • In Vitro Studies: Teicoplanin is used in laboratory settings to study bacterial resistance mechanisms and to evaluate the efficacy of new antimicrobial agents, providing insights that can lead to innovative treatments.
  • Combination Therapies: It is often investigated in combination with other antibiotics to enhance therapeutic outcomes, particularly in treating polymicrobial infections, thus broadening the scope of treatment options available to clinicians.

Citations